A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.

Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.

Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

It turns out we might be building up our brain when we exercise.” Betley is corresponding author of the researchers’ published paper in Neuron, titled “ Exercise-induced activation of ventromedial ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture.

Eli Lilly will shell out $2.4 billion to acquire genetic medicine developer Orna Therapeutics and has committed up to $8.85 billion to launch a seventh collaboration with Innovent Biologics. Both ...

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

Active Genetics (Pro-AG) exploits a naturally created bacterial mating tunnel between cells to inactivate antibiotic resistance.

Ion mobility adds a powerful new dimension to biopharma separations as complex therapeutics outgrow traditional LC–MS.

A new study has found bacterial sugars that cause neurodegenerative immune response, providing a mechanism for therapeutic intervention.

Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs through a multi-year tech and ...